Menu
RetailMVP
  • Home
  • News
  • Jobs
  • Network
    • BusinessMVP
    • FashionMVP
    • GroceryMVP
    • HospitalityMVP
    • HotelMVP
    • TravelMVP
Close Menu

Walgreens Files Definitive Proxy Statement/Final Prospectus Related to Special Shareholders Meeting

Pharmacy, Press Releases Walgreens

DEERFIELD, Ill., Nov. 25, 2014 – Walgreens (NYSE: WAG) (Nasdaq: WAG) today said that on Nov. 24 it filed and began mailing to its shareholders the definitive proxy statement/final prospectus relating to a special meeting of shareholders, which will take place Dec. 29 in New York City. This follows the announcement made on Aug. 6 when the company exercised its option to complete the second step of its strategic transaction with Alliance Boots.

At the special meeting, Walgreens shareholders will be asked to consider and vote upon, among other things:

a holding company reorganization to establish Walgreens Boots Alliance, Inc. as the new publicly-traded holding company of the new combined enterprise; and
the issuance of Walgreens Boots Alliance shares necessary to complete Step 2 of the strategic transaction.

Alliance Boots and Walgreens are making significant progress toward closing the transaction, which is expected before the end of the first quarter of calendar 2015.

About Walgreens
As the nation’s largest drugstore chain with fiscal 2014 sales of $76 billion, Walgreens (www.walgreens.com) vision is to be America’s most loved pharmacy-led health, wellbeing and beauty enterprise. Each day, in communities across America, more than 8 million customers interact with Walgreens using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with online and mobile services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,218 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens digital business includes Walgreens.com, drugstore.com, Beauty.com, SkinStore.com and VisionDirect.com. Walgreens also manages more than 400 Healthcare Clinic and provider practice locations around the country.

Important Information for Investors and Shareholders
In connection with the proposed transactions between Walgreen Co. (“Walgreens”) and Alliance Boots GmbH, Walgreens Boots Alliance, Inc. (“WBA”) has filed with the SEC a registration statement on Form S-4 and two amendments thereto, as well as a definitive prospectus of WBA and a definitive proxy statement of Walgreens in connection with the proposed transactions. The registration statement, as amended was declared effective by the SEC on November 24, 2014, and the definitive proxy statement/prospectus was mailed to Walgreens’ shareholders on or about November 24, 2014. INVESTORS AND SECURITY HOLDERS OF WALGREENS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND OTHER DOCUMENTS RELATING TO THE TRANSACTIONS THAT HAVE BEEN OR WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTIONS. Investors and security holders will be able to obtain free copies of the registration statement and the definitive proxy statement/prospectus and other documents filed with the SEC by Walgreens or WBA through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Walgreens or WBA will be available free of charge on Walgreens’ internet website at www.walgreens.com under the heading “Investor Relations” and then under the heading “SEC Filings” or by contacting Walgreens’ Investor Relations Department at (847) 315-2361.

Participants in the Solicitation
Walgreens, Alliance Boots GmbH, WBA and their respective directors, executive officers and certain other members of management and employees may be deemed to be participants in the solicitation of proxies from the holders of Walgreens common stock in respect of the proposed transactions. You can find information about Walgreens’ directors and executive officers in Walgreens’ Annual Report on Form 10-K for the year ended August 31, 2014, as amended. Additional information regarding the persons who are, under the rules of the SEC, participants in the solicitation of proxies in favor of the proposed transactions is set forth in the definitive proxy statement/prospectus. You can obtain free copies of these documents, which are filed with the SEC, from Walgreens using the contact information above.

SOURCE: Walgreens

Related Posts

Pharmacy, Press Releases, Retail

Walgreens to Present Research from Five Clinical Studies at International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting

Pharmacy, Press Releases, Retail

VA, VFW and Walgreens Collaborate to Enhance Veterans’ Access to Mental Health Resources

Pharmacy, Press Releases

Walgreens Flu Index™ for Week of Jan. 26, 2015

Featured News

  • Walmart and the Walmart Foundation Commit $25 Million to Global COVID-19 Response Effort
  • Kroger Family of Companies Announces Appreciation Bonus for Associates and Expands 14-Day COVID-19 Emergency Leave Guidelines
  • Lowe’s Commits $25 Million, Updates Operations in Response to COVID-19
  • Target Invests More Than $300 Million in Frontline Team Members with Added Wages, New Paid Leave Program, Bonus Payouts and Relief Fund Contributions
  • Publix hiring retail and distribution associates
Back To Top
RetailMVP
Copyright © BusinessMVP.com
All Rights Reserved!